Company Filing History:
Years Active: 2019
Title: Innovator Spotlight: Anders Gillis Holmén
Introduction
Anders Gillis Holmén, based in Molndal, Sweden, is an accomplished inventor known for his contributions in the field of pharmaceuticals. With a focus on innovative formulations, he has secured a notable patent that has potential implications for health and nutrition.
Latest Patents
Holmén holds a patent for "Millicapsule formulations comprising polyunsaturated free fatty acids." This patent showcases capsular dosage forms that include a unit dosage comprised of multiple millicapsules containing a polyunsaturated fatty acid (PUFA) composition. The invention highlights various embodiments, particularly those featuring capsular forms that incorporate PUFA substantially in free acid form. Notably, among the PUFA compositions is Epanova®, which has garnered attention for its health benefits.
Career Highlights
Anders Holmén is currently associated with Omthera Pharmaceuticals Inc., a company dedicated to advancing innovative pharmaceutical solutions. His expertise and innovative spirit have led to significant advancements in the field, reflecting his commitment to enhancing drug formulation processes.
Collaborations
Throughout his career, Holmén has collaborated with esteemed colleagues such as Hironori Kubota and Etienne Thierry Charles Rogeau. These partnerships illustrate a cooperative approach to research and development, fostering an environment that encourages groundbreaking discoveries in pharmaceutical sciences.
Conclusion
Anders Gillis Holmén exemplifies the role of inventors in driving innovation within the pharmaceutical industry. His dedication to developing advanced formulations will undoubtedly continue to impact health and wellness, positioning him as a notable figure in the realm of invention and research.